Jacqueline M Hirth1, Mihyun Chang2, Vicente A Resto3. 1. Center for Interdisciplinary Research in Women's Health, Department of Obstetrics & Gynecology, University of Texas Medical Branch, United States. Electronic address: jmhirth@utmb.edu. 2. Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch, United States. 3. Department of Otolaryngology, University of Texas Medical Branch, United States.
Abstract
BACKGROUND: Although there is evidence that human papillomavirus (HPV) vaccination may protect against oral HPV infection, no current research has demonstrated this in the general population. METHODS: We used repeated cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) between 2009 and 2014. Participants 18-30years who indicated whether they had received the HPV vaccine and provided an adequate oral sample were included (N=3040). Oral HPV types were grouped by vaccine-type (types 6, 11, 16, 18) and by risk (high or low risk). Chi-square analyses compared oral HPV prevalence by vaccination status. RESULTS: Vaccinated adults had a lower prevalence of vaccine-type oral HPV (types 6, 11, 16, 18) compared to unvaccinated adults. Prevalence of non-vaccine high-risk oral HPV was similar between HPV vaccinated and unvaccinated participants. CONCLUSIONS: HPV vaccination appears to provide protection against vaccine-type oral HPV infection among males and females in the general population.
BACKGROUND: Although there is evidence that human papillomavirus (HPV) vaccination may protect against oral HPV infection, no current research has demonstrated this in the general population. METHODS: We used repeated cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) between 2009 and 2014. Participants 18-30years who indicated whether they had received the HPV vaccine and provided an adequate oral sample were included (N=3040). Oral HPV types were grouped by vaccine-type (types 6, 11, 16, 18) and by risk (high or low risk). Chi-square analyses compared oral HPV prevalence by vaccination status. RESULTS: Vaccinated adults had a lower prevalence of vaccine-type oral HPV (types 6, 11, 16, 18) compared to unvaccinated adults. Prevalence of non-vaccine high-risk oral HPV was similar between HPV vaccinated and unvaccinated participants. CONCLUSIONS:HPV vaccination appears to provide protection against vaccine-type oral HPV infection among males and females in the general population.
Authors: Anil K Chaturvedi; Barry I Graubard; Tatevik Broutian; Robert K L Pickard; Zhen-Yue Tong; Weihong Xiao; Lisa Kahle; Maura L Gillison Journal: J Clin Oncol Date: 2017-11-28 Impact factor: 44.544
Authors: Stacey B Griner; Erika L Thompson; Cheryl A Vamos; Anil K Chaturvedi; Coralia Vazquez-Otero; Laura K Merrell; Nolan S Kline; Ellen M Daley Journal: Hum Vaccin Immunother Date: 2019-02-20 Impact factor: 3.452
Authors: Mary Roz Timbang; Michael W Sim; Arnaud F Bewley; D Gregory Farwell; Avinash Mantravadi; Michael G Moore Journal: Hum Vaccin Immunother Date: 2019-05-07 Impact factor: 3.452
Authors: Kalyani Sonawane; Ryan Suk; Elizabeth Y Chiao; Jagpreet Chhatwal; Peihua Qiu; Timothy Wilkin; Alan G Nyitray; Andrew G Sikora; Ashish A Deshmukh Journal: Ann Intern Med Date: 2017-10-17 Impact factor: 25.391